𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of moderate or severe liver dysfunction on the pharmacokinetics of γ-hydroxybutyric acid

✍ Scribed by S. D. Ferrara; L. Tedeschi; G. Frison; R. Orlando; M. Mazzo; R. Zordan; R. Padrini; P. Palatini

Book ID
105922533
Publisher
Springer
Year
1996
Tongue
English
Weight
289 KB
Volume
50
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of benzodiazepine antag
Pharmacokinetics of benzodiazepine antagonist Ro 15–1788 in cirrhotic patients with moderate or severe liver dysfunction
✍ Gilles Pomier-Layrargues; J.-François Giguère; Joël Lavoie; Bernard Willems; Rog 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB

Ro 15-1788, a benzodiazepine antagonist, has been advocated as a new treatment for hepatic encephalopathy. This drug is extensively metabolized by the liver in normal subjects. In the present study, we examined Ro 15-1 788 disposition in eight healthy controls (Group I), eight cirrhotic patients wit

The effect of liver dysfunction on colch
The effect of liver dysfunction on colchicine pharmacokinetics in the rat
✍ Jonathan A. Leighton; Michael K. Bay; Alma L. Maldonado; Raymond F. Johnson; Ste 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

Recent work has shown that colchicine may benefit patients with primary biliary or alcoholic cirrhosis. However, very little is known about its pharmacokinetics in the presence of impaired liver function. To study this w e examined the effects of three models of experimental liver dysfunction and on